Glioma survival prediction with combined analysis of in vivo 11C-MET PET features, ex vivo features, and patient features by supervised machine learning
L Papp, N Pötsch, M Grahovac… - Journal of Nuclear …, 2018 - Soc Nuclear Med
Gliomas are the most common type of tumor in the brain. Although the definite diagnosis is
routinely made ex vivo by histopathologic and molecular examination, diagnostic work-up of …
routinely made ex vivo by histopathologic and molecular examination, diagnostic work-up of …
[PDF][PDF] Glioma Survival Prediction with Combined Analysis of In Vivo 11C-MET PET Features, Ex Vivo Features, and Patient Features by Supervised Machine Learning
L Papp, N Pötsch, M Grahovac… - THE JOURNAL OF …, 2018 - Soc Nuclear Med
MATERIALS AND METHODS Patient Data Seventy patients with histologically verified
treatment-naıve gliomas based on the WHO 2007 classification were collected from a …
treatment-naıve gliomas based on the WHO 2007 classification were collected from a …
[PDF][PDF] Glioma Survival Prediction with Combined Analysis of In Vivo 11C-MET PET Features, Ex Vivo Features, and Patient Features by Supervised Machine Learning
L Papp, N Pötsch, M Grahovac… - THE JOURNAL OF …, 2018 - scholar.archive.org
MATERIALS AND METHODS Patient Data Seventy patients with histologically verified
treatment-naıve gliomas based on the WHO 2007 classification were collected from a …
treatment-naıve gliomas based on the WHO 2007 classification were collected from a …
[PDF][PDF] Glioma Survival Prediction with Combined Analysis of In Vivo 11C-MET PET Features, Ex Vivo Features, and Patient Features by Supervised Machine Learning
L Papp, N Pötsch, M Grahovac… - THE JOURNAL OF …, 2018 - researchgate.net
MATERIALS AND METHODS Patient Data Seventy patients with histologically verified
treatment-naıve gliomas based on the WHO 2007 classification were collected from a …
treatment-naıve gliomas based on the WHO 2007 classification were collected from a …
[引用][C] Glioma Survival Prediction with Combined Analysis of In Vivo 11C-MET PET Features, Ex Vivo Features, and Patient Features by Supervised Machine …
L Papp, N Pötsch, M Grahovac… - Journal of Nuclear …, 2017 - cir.nii.ac.jp
Glioma Survival Prediction with Combined Analysis of In Vivo <sup>11</sup>C-MET PET
Features, Ex Vivo Features, and Patient Features by Supervised Machine Learning | CiNii …
Features, Ex Vivo Features, and Patient Features by Supervised Machine Learning | CiNii …
Glioma Survival Prediction with Combined Analysis of In Vivo 11C-MET PET Features, Ex Vivo Features, and Patient Features by Supervised Machine Learning
L Papp, N Pötsch, M Grahovac… - Journal of nuclear …, 2018 - pubmed.ncbi.nlm.nih.gov
Gliomas are the most common type of tumor in the brain. Although the definite diagnosis is
routinely made ex vivo by histopathologic and molecular examination, diagnostic work-up of …
routinely made ex vivo by histopathologic and molecular examination, diagnostic work-up of …
[PDF][PDF] Glioma Survival Prediction with Combined Analysis of In Vivo 11C-MET PET Features, Ex Vivo Features, and Patient Features by Supervised Machine Learning
L Papp, N Pötsch, M Grahovac… - THE JOURNAL OF …, 2018 - academia.edu
MATERIALS AND METHODS Patient Data Seventy patients with histologically verified
treatment-naıve gliomas based on the WHO 2007 classification were collected from a …
treatment-naıve gliomas based on the WHO 2007 classification were collected from a …
Glioma Survival Prediction with Combined Analysis of In Vivo 11C-MET PET Features, Ex Vivo Features, and Patient Features by Supervised Machine Learning.
L Papp, N Pötsch, M Grahovac… - Journal of Nuclear …, 2017 - europepmc.org
Gliomas are the most common type of tumor in the brain. Although the definite diagnosis is
routinely made ex vivo by histopathologic and molecular examination, diagnostic work-up of …
routinely made ex vivo by histopathologic and molecular examination, diagnostic work-up of …